Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIME: Suboxone vs Subutex for IV Buprenorphine Misuse
NCT00955162Phase 4Completed
- Sponsor
- Indivior
- Start
- Aug 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of buprenorphine + naloxone in opioid use disorder (OUD) (2 arms), sponsored by Indivior. Primary endpoint: Number of study drug injections per week at 1 week. Started Aug 2009; status: completed.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00955162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00955162.